Web resources

 Tumours list


   General information
   Urologic tumour list

   General information
   Rare melanoma list

   General information
   Skin tumor list


(GLS - italian project)
   Info generali
   Scheda dati

   General information
   Member area


partially supported by


17/11/2001 - W.H.O. Collaborating Centre for Cancer Control of Uncommon Tumours

Tfdhe list of tumours which may be defined uncommon (i.e., those tumours whose incidence is (2/100.000) is by no means minuscular. Their low frequency and the ensuing difficulty in collecting at a single Centre a number of cases sufficient to become experienced with their management, make their clinical and histopathologic identification as well as their prognostic evaluation and treatment a difficult task. Unlike what happens with common tumours, the clinical and basic research studies on uncommon tumours are scarce, and the institutions which can undertake their diagnosis and treatment very few. Furthermore, for the diagnosis of uncommon tumours is often necessary to resort to sophisticated machinery or laboratory techniques not widely available or affordable. Another limiting factor is given by the lack of financial support, which is mainly conveyed on studies on those tumours that, because of their high frequency, have a stronger social impact.A means to circumvent these drawbacks is offered by the World Health Organization Collaborating Centres. These are national institutions designated by the UN sanitary arm as reference centres for the study of medical-social problems, including cancer. By definition, a WHO Collaborating Centre forms part of an inter-institutional collaborative network set up by W.H.O. at the national and international levels, thus contributing to the local and global development of specific health resources.

News Archive

3/8/2001 WHY?
10/12/2001 On November 30th, in the hall of the S. Pio X Private Hospital of Milan, Italy, the
18/12/2001 Post-meeting survey
3/12/2002 QUIZ
5/5/2002 Dear Colleagues,Notebook Veri Kurtarma
29/01/2003 New publication on rare cancers !
28/07/2003 Thyroid Cancer Treatment Receives Orphan Drug Status
02/08/2003 Breast cancer in men Kiralık Ofis Ankara
24/09/2003 GISTs: The revolution continues
28/10/2003 Lessons learned from the management of a rare genetic cancer.
17/11/2003 Successful photodynamic therapy for nonresectable cholangiocarcinoma.
07/01/2004 Gene associated with higher risk of melanoma in men
08/03/2004 Susceptibility to Common Adult Cancers in Retinoblastoma Survivors
29/03/2004 FDA Approves First Drug for mesothelioma
25/08/2004 Gene therapy cures malignant melanoma in mice
20/10/2004 FDA grants orphan drug status to two new anticancer drugs.
15/11/2004 New experimental drug for myeloproliferative disorder
20/01/2005 New leukemia treatment granted FDA orphan drug status.
28/02/2005 U.S. F.D.A. grants new orphan drug designation for a targeted therapeutic for head and neck cancer.
02/05/2005 Possible targets for a multiple myeloma vaccine
17/10/2005 Orphan drug troxacitabine approved for AML in EU
03/11/2005 FDA designes interleukin 21 as an orphan drug
01/12/2005 Zactima has received FDA orphan drug designation
25/01/2006 CETT Program for Rare Genetic Diseases
23/02/2006 New research studies of multiple myeloma